Rabies vaccination of 6‐week‐old puppies born to immunized mothers: a randomized controlled trial in a high‐mortality population of owned, free‐roaming dogs
dc.contributor.author | Arega, Sintayehu | |
dc.contributor.author | Conan, Anne | |
dc.contributor.author | Sabeta, Claude Taurai | |
dc.contributor.author | Crafford, Jan Ernst | |
dc.contributor.author | Wentzel, Jeanette Maria | |
dc.contributor.author | Reininghaus, Bjorn | |
dc.contributor.author | Biggs, Louise Joanne | |
dc.contributor.author | Leisewitz, Andrew L. | |
dc.contributor.author | Quan, Melvyn | |
dc.contributor.author | Toka, Felix | |
dc.contributor.author | Knobel, Darryn Leslie | |
dc.date.accessioned | 2021-04-06T09:30:26Z | |
dc.date.available | 2021-04-06T09:30:26Z | |
dc.date.issued | 2020-03 | |
dc.description | Supplementary Materials: Table S1. Results of sensitivity analysis for survival analysis (6 to 13 weeks of age), considering subjects reported as lost or stolen by owners as dead (n = 22); Table S2. Results of sensitivity analysis for survival analysis (6 to 13 weeks of age), censoring subjects that reportedly died from accidents (n = 5). | en_ZA |
dc.description.abstract | To achieve global elimination of human rabies from dogs by 2030, evidence-based strategies for effective dog vaccination are needed. Current guidelines recommend inclusion of dogs younger than 3 months in mass rabies vaccination campaigns, although available vaccines are only recommended for use by manufacturers in older dogs, ostensibly due to concerns over interference of maternally-acquired immunity with immune response to the vaccine. Adverse effects of vaccination in this age group of dogs have also not been adequately assessed under field conditions. In a single-site, owner-blinded, randomized, placebo-controlled trial in puppies born to mothers vaccinated within the previous 18 months in a high-mortality population of owned, free-roaming dogs in South Africa, we assessed immunogenicity and effect on survival to all causes of mortality of a single dose of rabies vaccine administered at 6 weeks of age. We found that puppies did not have appreciable levels of maternally-derived antibodies at 6 weeks of age (geometric mean titer 0.065 IU/mL, 95% CI 0.061–0.069; n = 346), and that 88% (95% CI 80.7–93.3) of puppies vaccinated at 6 weeks had titers ≥0.5 IU/mL 21 days later (n = 117). Although the average effect of vaccination on survival was not statistically significant (hazard ratio [HR] 1.35, 95% CI 0.83–2.18), this effect was modified by sex (p = 0.02), with the HR in females 3.09 (95% CI 1.24–7.69) and the HR in males 0.79 (95% CI 0.41–1.53). We speculate that this effect is related to the observed survival advantage that females had over males in the unvaccinated group (HR 0.27; 95% CI 0.11–0.70), with vaccination eroding this advantage through as-yet-unknown mechanisms. | en_ZA |
dc.description.department | Companion Animal Clinical Studies | en_ZA |
dc.description.department | Production Animal Studies | en_ZA |
dc.description.department | Veterinary Tropical Diseases | en_ZA |
dc.description.librarian | hj2021 | en_ZA |
dc.description.uri | http://www.mdpi.com/journal/tropicalmed | en_ZA |
dc.identifier.citation | Arega, S., Conan, A., Sabeta, C.T. et al. 2020, 'Rabies vaccination of 6‐week‐old puppies born to immunized mothers: a randomized controlled trial in a high‐mortality population of owned, free‐roaming dogs', Tropical Medicine and Infectious Disease 5(1): 45, doi: 10.3390/tropicalmed5010045. | en_ZA |
dc.identifier.issn | 2414-6366 (online) | |
dc.identifier.other | 10.3390/tropicalmed5010045 | |
dc.identifier.uri | http://hdl.handle.net/2263/79312 | |
dc.language.iso | en | en_ZA |
dc.publisher | MDPI | en_ZA |
dc.rights | © 2020 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). | en_ZA |
dc.subject | Immunogenicity | en_ZA |
dc.subject | Mortality | en_ZA |
dc.subject | Maternally-acquired immunity | en_ZA |
dc.subject | Sex | en_ZA |
dc.subject | Nonspecific effects of vaccines | en_ZA |
dc.subject.other | Veterinary science articles SDG-03 | en_ZA |
dc.subject.other | SDG-03: Good health and well-being | |
dc.title | Rabies vaccination of 6‐week‐old puppies born to immunized mothers: a randomized controlled trial in a high‐mortality population of owned, free‐roaming dogs | en_ZA |
dc.type | Article | en_ZA |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.75 KB
- Format:
- Item-specific license agreed upon to submission
- Description: